All companies
Visit website
NuEyes
OperatingNuEyes Technologies Inc.
Healthcare · Founded 2016
Wearable Technology of the Future
Post-money valuation ⓘ
$25.1M
As of May 2021 · from NuEyes · pre-money + amount raised, not a traded price
Total raised
$52,912
Across 1 round since 2020
Latest share price
$43.00
NuEyes offering price
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its source$1.0M
−$663K
2018
$933K
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
Income statement
Revenue
$1,012,566
$932,958
Cost of goods sold
$517,307
$354,050
Gross margin
49%
62%
Net income
-$663,047
$0
Taxes paid
$0
$0
Balance sheet
Cash
$8,610
$8,404
Accounts receivable
$0
$0
Total assets
$148,615
$135,474
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.1M
post-money
NuEyes
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $52.9K / $1.1MInvestors 108Post-money $25.1M
Reg CF annual-report compliance
Delinquent
Filed 0 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2021, 2022, 2023, 2024, 2025
108 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001828370Share price $43.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.